IASLC - TTLC Molecular Tumor Board

In this episode of Lung Cancer Considered, host Dr. Narjust Florez conducts three mock molecular tumor boards with Dr. Misako Nagasaka and Dr. Biagio Ricciuti, live from the Targeted Therapies of Lung Cancer (TTLC) 2026 conference. The discussion addresses the question, “How do we get the right molecular answer, at the right time, for the right patient?” Guests: Misako Nagasaka, MD, PhD Associate Clinical Professor University of California, Irvine Biagio Ricciuti, MD, PhD Thoracic Medical Oncologist, Dana-Farber Cancer Institute Faculty, Harvard School of Medicine

You can listen to IASLC - TTLC Molecular Tumor Board online on Radio and Podcast. Open the player on this page to stream the available audio.

IASLC - TTLC Molecular Tumor Board is an episode from Lung Cancer Considered by Lung Cancer Considered.

This episode is 00:54:47 long.

This episode was published on Mar 17, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Lung Cancer Considered when more episodes are available from the podcast feed.